Japan drugmaker Takeda says will fight $7.5b US damages order

TOKYO (AFP) - Japanese drug giant Takeda Pharmaceutical said on Tuesday it would fight a huge US$6.0 billion (S$7.5 billion) damages order following a US trial over the safety of one of its diabetes medicines.

The company said it "respectfully disagrees" with the judgement awarded by a jury in the southern state of Louisiana on Monday, which also ordered the firm's co-defendant US drugs firm Eli Lilly to pay US$3.0 billion in damages.